Literature DB >> 29920400

Improved de novo sequencing of heparin/heparan sulfate oligosaccharides by propionylation of sites of sulfation.

Quntao Liang1, Pradeep Chopra2, Geert-Jan Boons2, Joshua S Sharp3.   

Abstract

The structure of heparin and heparan sulfate (Hep/HS) oligosaccharides, as determined by the length and the pattern of sulfation, acetylation, and uronic acid epimerization, dictates their biological function through modulating interactions with protein targets. But fine structural determination is a very challenging task due to the lability of the sulfate modifications and difficulties in separating isomeric HS chains. Previously, we reported a strategy for chemical derivatization involving permethylation, desulfation, and trideuteroperacetylation, combined with standard reverse phase LC-MS/MS that enables the structural sequencing for heparin/HS oligosaccharides of sizes up to dodecasaccharide by positionally replacing all sulfates with more stable trideuteroacetyl groups, allowing for robust MS/MS sequencing. However, isomeric oligosaccharides that contain both N-sulfation and N-acetylation become isotopomers after labeling, differing only in the sites of deuteration. This prevents chromatographic separation of these different mixed domain sequences post-derivatization, and makes sequencing by MS/MS difficult due to co-fragmentation of the isotopomers leading to chimeric product ion spectra. In order to improve chromatographic separation of mixed domain oligosaccharides, we have introduced a propionylation step in place of trideuteroacetylation for labeling of sites of sulfation. HS standard disaccharides have been used to evaluate the efficiency of this improved chemical derivatization. The results show that we can quantitatively replace sulfation with propionyl groups with the same high efficiency as the previously reported trideuteroacetylation. After derivatization, we demonstrate the ability to chromatographically separate two mixed domain tetrasaccharide isomers differing solely by the order of N-sulfation and N-acetylation, allowing for full sequencing of each by MS/MS. These results represent a marked improvement in the ability of our previously reported derivatization strategy to analyze complex mixtures of Hep/HS oligosaccharides without a decrease in sensitivity.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Chemical derivatization; Glycosaminoglycans; Heparin/heparan sulfate; LC-MS/MS

Mesh:

Substances:

Year:  2018        PMID: 29920400      PMCID: PMC6286702          DOI: 10.1016/j.carres.2018.06.002

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  26 in total

Review 1.  Cellular functions of proteoglycans--an overview.

Authors:  N Perrimon; M Bernfield
Journal:  Semin Cell Dev Biol       Date:  2001-04       Impact factor: 7.727

2.  An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides.

Authors:  Rongrong Huang; Jian Liu; Joshua S Sharp
Journal:  Anal Chem       Date:  2013-05-28       Impact factor: 6.986

3.  Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.

Authors:  M Fannon; K E Forsten; M A Nugent
Journal:  Biochemistry       Date:  2000-02-15       Impact factor: 3.162

4.  High structural resolution hydroxyl radical protein footprinting reveals an extended Robo1-heparin binding interface.

Authors:  Zixuan Li; Heather Moniz; Shuo Wang; Annapoorani Ramiah; Fuming Zhang; Kelley W Moremen; Robert J Linhardt; Joshua S Sharp
Journal:  J Biol Chem       Date:  2015-03-09       Impact factor: 5.157

Review 5.  Syndecans in inflammation.

Authors:  Martin Götte
Journal:  FASEB J       Date:  2003-04       Impact factor: 5.191

6.  Sodium hydroxide permethylation of heparin disaccharides.

Authors:  Christian Heiss; Zhirui Wang; Parastoo Azadi
Journal:  Rapid Commun Mass Spectrom       Date:  2011-03-30       Impact factor: 2.419

7.  The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.

Authors:  Zhengliang L Wu; Lijuan Zhang; Tomio Yabe; B Kuberan; David L Beeler; Andre Love; Robert D Rosenberg
Journal:  J Biol Chem       Date:  2003-02-25       Impact factor: 5.157

Review 8.  Heparin and heparan sulfate: structure and function.

Authors:  Dallas L Rabenstein
Journal:  Nat Prod Rep       Date:  2002-06       Impact factor: 13.423

9.  Integrated Approach to Identify Heparan Sulfate Ligand Requirements of Robo1.

Authors:  Chengli Zong; Rongrong Huang; Eduard Condac; Yulun Chiu; Wenyuan Xiao; Xiuru Li; Weigang Lu; Mayumi Ishihara; Shuo Wang; Annapoorani Ramiah; Morgan Stickney; Parastoo Azadi; I Jonathan Amster; Kelley W Moremen; Lianchun Wang; Joshua S Sharp; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2016-09-27       Impact factor: 15.419

Review 10.  Heparan sulfate proteoglycans: a sugar code for vertebrate development?

Authors:  Fabienne E Poulain; H Joseph Yost
Journal:  Development       Date:  2015-10-15       Impact factor: 6.868

View more
  6 in total

1.  Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.

Authors:  Ritesh Tandon; Joshua S Sharp; Fuming Zhang; Vitor H Pomin; Nicole M Ashpole; Dipanwita Mitra; Martin G McCandless; Weihua Jin; Hao Liu; Poonam Sharma; Robert J Linhardt
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

2.  Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates.

Authors:  Richard Karlsson; Pradeep Chopra; Apoorva Joshi; Zhang Yang; Sergey Y Vakhrushev; Thomas Mandel Clausen; Chelsea D Painter; Gergo P Szekeres; Yen-Hsi Chen; Daniel R Sandoval; Lars Hansen; Jeffrey D Esko; Kevin Pagel; Douglas P Dyer; Jeremy E Turnbull; Henrik Clausen; Geert-Jan Boons; Rebecca L Miller
Journal:  Sci Adv       Date:  2021-12-22       Impact factor: 14.136

3.  Commercial Low Molecular Weight Heparins - Patent Ecosystem and Technology Paradigm for Quality Characterization.

Authors:  Zarina Iqbal; Saima Sadaf
Journal:  J Pharm Innov       Date:  2022-07-28       Impact factor: 2.538

Review 4.  Analysis of the Glycosaminoglycan Chains of Proteoglycans.

Authors:  Yuefan Song; Fuming Zhang; Robert J Linhardt
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

5.  Salt-free fractionation of complex isomeric mixtures of glycosaminoglycan oligosaccharides compatible with ESI-MS and microarray analysis.

Authors:  Hao Liu; Apoorva Joshi; Pradeep Chopra; Lin Liu; Geert-Jan Boons; Joshua S Sharp
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

Review 6.  Developments in Mass Spectrometry for Glycosaminoglycan Analysis: A Review.

Authors:  Lauren E Pepi; Patience Sanderson; Morgan Stickney; I Jonathan Amster
Journal:  Mol Cell Proteomics       Date:  2021-01-06       Impact factor: 5.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.